[HTML][HTML] Immunosuppression and liver transplantation
J Lerut, S Iesari - Engineering, 2023 - Elsevier
Perfect surgical techniques and adequate immunosuppression are key to ensuring optimal
graft and patient survival. The availability of different drugs has led to several, often industry …
graft and patient survival. The availability of different drugs has led to several, often industry …
Intragraft regulatory T cells in the modern era: what can high-dimensional methods tell us about pathways to allograft acceptance?
KF Bei, S Moshkelgosha, BJ Liu, S Juvet - Frontiers in Immunology, 2023 - frontiersin.org
Replacement of diseased organs with transplanted healthy donor ones remains the best
and often only treatment option for end-stage organ disease. Immunosuppressants have …
and often only treatment option for end-stage organ disease. Immunosuppressants have …
[HTML][HTML] European Society for Organ Transplantation Consensus Statement on Biomarkers in Liver Transplantation
M Berenguer, E de Martin… - Transplant …, 2023 - frontierspartnerships.org
Currently, one-year survival following liver transplantation (LT) exceeds 90% in large
international registries, and LT is considered definitive treatment for patients with end-stage …
international registries, and LT is considered definitive treatment for patients with end-stage …
Time since liver transplant and immunosuppression withdrawal outcomes: Systematic review and individual patient data meta‐analysis
C Appenzeller‐Herzog, A Rosat, T Mathes… - Liver …, 2024 - Wiley Online Library
Abstract Background & Aims Successful immunosuppression withdrawal (ISW) is possible
for a subfraction of liver transplant (LT) recipients but the factors that define the risk of ISW …
for a subfraction of liver transplant (LT) recipients but the factors that define the risk of ISW …